Physician profile
Robert C Floros
NPI 1508843830
$2,229.53
in general payments reported to CMS, 2019-2025
16 companies · $32.63 in 2025
The $32.63 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $224 · 2021: $795 · 2022: $403 · 2023: $151 · 2024: $113 · 2025: $32.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $774.29 | 2019-2023 | Puraply |
| Next Science LLC | $273.77 | 2020-2022 | |
| Stryker Corporation | $270.06 | 2019-2024 | Variax |
| Cerapedics INC. | $194.69 | 2021-2022 | |
| Horizon Therapeutics Plc | $124.95 | 2019 | |
| Baxter Healthcare | $114.80 | 2019-2020 | |
| Nevro Corp. | $109.49 | 2022 | |
| Embody, INC. | $98.72 | 2021 | |
| Smith+Nephew, INC. | $72.34 | 2019-2025 | Collagenase Santyl, Stravix |
| Zimmer Biomet Holdings, INC. | $63.72 | 2022-2024 | Tapestry |
| Kerecis Limited | $61.01 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Reapplix INC. | $18.14 | 2021 | |
| Convatec INC. | $15.05 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.42 | 2022 | |
| Reprise Biomedical, INC. | $12.36 | 2023 | Miro3d |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Floros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.